Skip to main content
Premium Trial:

Request an Annual Quote

Functional Genomics Co. BioSource Appoints New CEO

NEW YORK, Sept. 26 – Functional genomics company BioSource International said Wednesday it had appointed Leonard Hendrickson president and CEO.

Until now, Hendrickson has been serving as the president and director of Isotope Products Laboratories. He has also been a director of BioSource of Camarillo, Calif., since 1993.

Hendrickson will replace James Chamberlain, the company’s founder and former president and CEO, who returned from retirement in May to serve as interim CEO.

Hendrickson said his first task would be to jumpstart sales for the company. 

"My first job will be to strategically position the company for accelerated top-line growth,” Hendrickson said in a statement.

BioSource develops reagent systems for genomics and proteomics that are designed to facilitate the discovery of new treatments.

Hendrickson will assume the duties of CEO on October 15.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.